Jones PH - Search Results

1

Vasudevan AR, Wu H, Xydakis AM, Jones PH, Smith EO, Sweeney JF, Corry DB, Ballantyne CM. Vasudevan AR, et al. Among authors: jones ph. J Clin Endocrinol Metab. 2006 Jan;91(1):256-61. doi: 10.1210/jc.2005-1280. Epub 2005 Nov 1. J Clin Endocrinol Metab. 2006. PMID: 16263831

2

Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system.

Liu MY, Xydakis AM, Hoogeveen RC, Jones PH, Smith EO, Nelson KW, Ballantyne CM. Liu MY, et al. Among authors: jones ph. Clin Chem. 2005 Jul;51(7):1102-9. doi: 10.1373/clinchem.2004.047084. Clin Chem. 2005. PMID: 15976097

3

Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction.

Xydakis AM, Case CC, Jones PH, Hoogeveen RC, Liu MY, Smith EO, Nelson KW, Ballantyne CM. Xydakis AM, et al. Among authors: jones ph. J Clin Endocrinol Metab. 2004 Jun;89(6):2697-703. doi: 10.1210/jc.2003-031826. J Clin Endocrinol Metab. 2004. PMID: 15181044

4

CD11c expression in adipose tissue and blood and its role in diet-induced obesity.

Wu H, Perrard XD, Wang Q, Perrard JL, Polsani VR, Jones PH, Smith CW, Ballantyne CM. Wu H, et al. Among authors: jones ph. Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):186-92. doi: 10.1161/ATVBAHA.109.198044. Epub 2009 Nov 12. Arterioscler Thromb Vasc Biol. 2010. PMID: 19910635 Free PMC article.

5

Effectiveness and tolerability of adding ezetimibe to niacin-based regimens for treatment of primary hyperlipidemia.

Jelesoff NE, Ballantyne CM, Xydakis AM, Chiou P, Jones PH, Guyton JR. Jelesoff NE, et al. Among authors: jones ph. Endocr Pract. 2006 Mar-Apr;12(2):159-64. doi: 10.4158/EP.12.2.159. Endocr Pract. 2006. PMID: 16690463

6

Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome.

Vasudevan M, Tchoua U, Gillard BK, Jones PH, Ballantyne CM, Pownall HJ. Vasudevan M, et al. Among authors: jones ph. J Clin Lipidol. 2013 Nov-Dec;7(6):661-70. doi: 10.1016/j.jacl.2013.05.004. Epub 2013 May 25. J Clin Lipidol. 2013. PMID: 24314365 Free PMC article.

7

Impact of weight loss on the metabolic syndrome.

Case CC, Jones PH, Nelson K, O'Brian Smith E, Ballantyne CM. Case CC, et al. Among authors: jones ph. Diabetes Obes Metab. 2002 Nov;4(6):407-14. doi: 10.1046/j.1463-1326.2002.00236.x. Diabetes Obes Metab. 2002. PMID: 12406040

8

Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.

Xydakis AM, Guyton JR, Chiou P, Stein JL, Jones PH, Ballantyne CM. Xydakis AM, et al. Among authors: jones ph. Am J Cardiol. 2004 Sep 15;94(6):795-7. doi: 10.1016/j.amjcard.2004.06.008. Am J Cardiol. 2004. PMID: 15374793

9

Effective use of combination lipid therapy.

Vasudevan AR, Jones PH. Vasudevan AR, et al. Among authors: jones ph. Curr Cardiol Rep. 2005 Nov;7(6):471-9. doi: 10.1007/s11886-005-0066-7. Curr Cardiol Rep. 2005. PMID: 16256018 Review.

10

Effective use of combination lipid therapy.

Vasudevan AR, Jones PH. Vasudevan AR, et al. Among authors: jones ph. Curr Atheroscler Rep. 2006 Jan;8(1):76-84. doi: 10.1007/s11883-006-0068-y. Curr Atheroscler Rep. 2006. PMID: 16455018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

452 results

Search Page